Wound Care Market Growth Drivers and Challenges:
Growth Drivers
- Rising Incidence of Chronic Wounds: Chronic wounds such as diabetic foot ulcers and pressure ulcers are becoming increasingly common, driving demand for wound care products. According to the World Health Organization (WHO), an estimated 422 million people worldwide have diabetes, with around 20% of them developing diabetic foot ulcers. Additionally, the prevalence of pressure ulcers is estimated to be between 10% and 18% in hospital settings.
- Increasing Geriatric Population: The aging population is more prone to developing chronic wounds, hence increasing the demand for wound care products. According to the United Nations, the number of people aged 65 years and older is projected to more than double by the year 2050, reaching 1.5 billion globally.
- Growing Number of Surgeries: As mentioned earlier, surgical wounds require proper care to prevent infection and promote healing. According to a report, around 313 million surgeries are performed each year, with this number projected to increase in the coming years.
Challenges
- High Cost: Advanced wound care products can be expensive, making it difficult for patients to access them. This is particularly problematic in low- and middle-income countries, where patients may not have access to adequate healthcare.
- Lack of reimbursement
- Product development costs
Wound Care Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
5.9% |
|
Base Year Market Size (2025) |
USD 21.99 billion |
|
Forecast Year Market Size (2035) |
USD 39.01 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of wound care is evaluated at USD 23.16 billion.
The global wound care market size exceeded USD 21.99 billion in 2025 and is set to register a CAGR of more than 5.9%, exceeding USD 39.01 billion revenue by 2035.
North America wound care market will hold over 35% share by 2035, robust medical infrastructure and increase in surgical procedures.
Key players in the market include Arch Therapeutics, Inc., Convatec Group PLC, 3M Healthcare, Convatec Group PLC, Coloplast A/S, Cardinal Health, B. Braun Melsungen AG, Acelity L.P. Inc., Integra Lifesciences Holdings Corporation, Medtronic plc.
